The Liv Hospital Medical Writer Team creates evidence-based health content.
View author profile →Overview
What Is Invasive Lobular Carcinoma?
Invasive lobular carcinoma is a type of breast cancer that starts in the milk-producing lobules, the small glands that make breast milk. The cancer cells can grow beyond the lobules and invade nearby breast tissue. It is a form of invasive breast cancer, also called invasive lobular breast cancer or lobular carcinoma. Although it can affect anyone with breast tissue, it occurs most often in women and may grow in a less clearly defined pattern than some other breast cancers.
Symptoms
Symptoms of Invasive Lobular Carcinoma
Symptoms of invasive lobular carcinoma can be subtle, and some people have no obvious symptoms at first. A new breast or underarm change should be assessed by a clinician rather than diagnosed at home. Symptoms can have many causes, but prompt evaluation helps identify breast cancer or other conditions early.
- A thickened or firm area in the breast (breast thickening)
- Swelling in part or all of the breast
- A change in breast size, shape, or contour
- Dimpling or pulling in of the breast skin
- A nipple that turns inward (nipple inversion)
- Nipple discharge, especially if it is new or bloody
- Enlarged lymph nodes in the underarm or near the collarbone
Causes
What Causes Invasive Lobular Carcinoma?
Invasive lobular carcinoma develops when genetic changes cause cells lining the breast lobules to grow abnormally and invade surrounding tissue. Lobular tumors often have reduced activity of a cell-adhesion protein called E-cadherin, which normally helps cells stay attached in organized groups. This may contribute to the single-file or diffuse growth pattern seen in lobular invasive cancer. These biological changes are different from risk factors, and an individual case usually cannot be attributed to one single cause.
Risk Factors
Risk Factors for Invasive Lobular Carcinoma
Nonmodifiable and partly modifiable factors
- Increasing age, since breast cancer risk generally rises over time.
- Female sex, although breast cancer can also occur in men and other people with breast tissue.
- A personal history of breast cancer or certain high-risk breast conditions.
- A close family history of breast cancer, which may reflect shared genes or shared environment but does not guarantee cancer will develop.
- Inherited mutations, such as changes in BRCA1, BRCA2, or other cancer-risk genes.
- Longer lifetime exposure to estrogen, including earlier menstruation, later menopause, or other hormonal factors.
- Previous chest radiation treatment, particularly at a younger age.
Potentially modifiable factors
- Alcohol use, because drinking alcohol is associated with increased breast cancer risk.
- Physical inactivity, which may be improved through regular activity suited to a person’s health.
- Excess body weight after menopause, which is associated with higher breast cancer risk.
- Some hormone therapy exposures, whose benefits and risks should be reviewed with a clinician.
- Smoking and other health behaviors that can affect overall cancer and treatment health, even though they do not explain every case of lobular carcinoma.
Side Effects & Complications
Side Effects and Complications
Possible complications of the disease
Invasive lobular carcinoma can spread to nearby lymph nodes or, in advanced disease, to distant organs such as the bones, liver, lungs, or brain. It can return in the breast, chest wall, or elsewhere after treatment, and its diffuse growth may make the tumor harder to detect or define on imaging. How serious invasive lobular carcinoma is depends on its stage, grade, receptor status, tumor biology, overall health, and response to treatment—not on the word “lobular” alone. For example, an invasive lobular carcinoma grade 2 has an intermediate grade, but its outlook still depends on the full pathology and staging picture.
Possible treatment-related effects
Surgery may cause pain, scarring, changes in breast appearance, reduced shoulder movement, or arm swelling from lymphedema. Radiation therapy can cause skin irritation, breast or chest-wall changes, and fatigue. Endocrine therapy may cause hot flashes, joint or muscle symptoms, sexual health changes, or bone effects. Chemotherapy can cause fatigue, nausea, hair loss, infection risk, nerve symptoms, and changes in blood counts. Targeted therapy and immunotherapy can cause medication-specific effects, including heart problems, infusion reactions, or inflammation of organs in selected patients.
When to call
Report serious treatment symptoms promptly
Contact your treatment team promptly for a fever during chemotherapy, new or worsening breathing difficulty, chest pain, severe allergic symptoms, or sudden weakness, confusion, vision changes, or trouble speaking.
Diagnosis & Staging
Diagnosis and Staging
Evaluation usually begins with a breast and underarm examination. Diagnostic mammography, ultrasound, or breast MRI may help identify an area of concern, but a core needle biopsy is generally needed to confirm invasive lobular carcinoma. The biopsy sample is examined by a pathologist, and laboratory testing helps characterize the tumor and guide treatment.
Pathology and tumor features
The pathology report may identify invasive lobular histology, tumor grade, and whether the cancer cells have estrogen receptors or progesterone receptors. It also reports HER2 status, which can affect the use of targeted treatment. Selected genomic or molecular tests may help estimate recurrence risk or whether chemotherapy is likely to add benefit. These details help distinguish lobular breast cancer from invasive ductal carcinoma and other types of invasive mammary carcinoma.
| Stage | General meaning | What may affect the stage |
|---|---|---|
| Stage 0 | Noninvasive disease confined to its original location | Whether invasion is present |
| Stage I | Small invasive cancer with no or limited nearby involvement | Tumor size and lymph nodes |
| Stage II | Larger tumor or more nearby lymph-node involvement | Tumor size and regional spread |
| Stage III | More extensive regional breast, chest-wall, skin, or lymph-node disease | Local and regional extent |
| Stage IV | Cancer that has spread to distant organs | Metastatic sites |
Treatment Options
Treatment Options
| Modality | Main purpose | Examples of when it may be used |
|---|---|---|
| Surgery | Remove the tumor and assess regional disease | Breast-conserving surgery or mastectomy, with selected lymph-node surgery |
| Radiation therapy | Reduce the chance of cancer returning in treated areas | Often after breast-conserving surgery and for selected higher-risk situations |
| Endocrine therapy | Block or lower hormone signaling | Hormone-receptor-positive disease |
| Chemotherapy | Treat rapidly dividing cancer cells throughout the body | Selected higher-risk or biologically aggressive disease |
| Targeted or immunotherapy | Act on specific tumor markers or immune pathways | Only when tumor testing and clinical indications support use |
Lumpectomy removes the cancer with a margin of surrounding tissue, while mastectomy removes most or all breast tissue; the appropriate option depends on tumor extent, breast size, imaging findings, genetic risk, and personal preference. Lymph-node evaluation may be recommended to determine whether cancer has reached nearby nodes. Because lobular tumors can be diffuse or involve more than one area, imaging may influence whether lumpectomy for invasive lobular carcinoma is suitable. A breast surgeon can discuss margins, reconstruction, and the expected cosmetic result.
How treatment may be sequenced
Some people receive neoadjuvant treatment before surgery to shrink the cancer or test how it responds, while others begin with surgery and receive adjuvant treatment afterward. Reconstruction can be discussed before or after mastectomy, and rehabilitation may help with shoulder movement, strength, or lymphedema. The plan is individualized using stage, receptor status, grade, genomic findings, menopausal status, overall health, and preferences. Clinical trials and supportive care may be appropriate at any point.
Prevention & Screening
Prevention and Screening
Invasive lobular carcinoma cannot always be prevented, but some steps may lower overall breast cancer risk. Limiting alcohol, staying physically active, and maintaining a healthy weight may help, particularly after menopause. Discuss the benefits and risks of hormone therapy with a clinician, and consider genetic counseling if family history suggests inherited risk. These measures reduce risk for some people but cannot prevent every case of lobular breast cancer.
Breast cancer screening
Routine mammography recommendations depend on age, personal risk, and guidelines in your country. People with a strong family history, an inherited mutation, or certain personal risk factors may need earlier or more frequent mammography and supplemental breast MRI. A clinician or breast-risk specialist can help determine the most appropriate schedule.
Outlook and Prognosis
Outlook and Prognosis
The outlook for invasive lobular carcinoma depends mainly on the stage, lymph-node involvement, whether the cancer has spread, tumor grade, hormone and HER2 status, overall health, and response to treatment. People with the same diagnosis can have different outcomes because these features vary. Your oncology team can interpret pathology and staging results in the context of your treatment plan rather than relying on a general label alone.
More favorable factors
Earlier stage, fewer involved lymph nodes, and treatment-responsive tumor biology can be associated with better outcomes.
Higher-risk factors
Extensive regional disease, distant spread, aggressive tumor features, or limited response to treatment can make management more complex.
Survivorship & Follow-up
Survivorship and Follow-up
After treatment, a survivorship care plan usually includes scheduled oncology or primary care visits, breast imaging of remaining breast tissue or reconstructed areas when appropriate, medication review, and monitoring for treatment effects. Follow-up may also address bone health, heart health, menopause-related symptoms, lymphedema, emotional well-being, and returning to daily activities. Long-term endocrine therapy may be recommended for some people with hormone-receptor-positive invasive lobular breast cancer.
Changes to report between appointments
Tell your care team about a new breast or chest-wall change, persistent or worsening bone pain, unexplained weight loss, ongoing cough or breathing symptoms, severe headaches, weakness, numbness, confusion, or other neurologic changes. These symptoms do not always mean recurrence, but they should be assessed promptly. Continue prescribed medicines and attend recommended imaging and follow-up visits.
